Table 1.
Characteristics of newly diagnosed HIV-infected individuals by medication possession ratio, 2009–2016.
| Total (n = 8,501) | ≥95% (n = 5,981) | 80–95% (n = 798) | 50–80% (n = 654) | <50% (n = 1,068) | p valuea | |
|---|---|---|---|---|---|---|
| Gender | ||||||
| Men | 7,824 (92.0) | 5,560 (93.0) | 734 (92.0) | 595 (91.0) | 935 (87.5) | <0.0001 |
| Women | 677 (8.0) | 421 (7.0) | 64 (8.0) | 59 (9.0) | 133 (12.5) | |
| Age | ||||||
| 0–19 | 225 (2.6) | 143 (2.4) | 29 (3.6) | 23 (3.5) | 30 (2.8) | <0.0001 |
| 20–29 | 2,135 (25.1) | 1,548 (25.9) | 198 (24.8) | 192 (29.4) | 197 (18.4) | |
| 30–39 | 2,202 (25.9) | 1,579 (26.4) | 212 (26.6) | 161 (24.6) | 250 (23.4) | |
| 40–49 | 2,001 (23.5) | 1,386 (23.2) | 197 (24.7) | 149 (22.8) | 269 (25.2) | |
| Over 50 | 1,938 (22.8) | 1,325 (22.2) | 162 (20.3) | 129 (19.7) | 322 (30.1) | |
| AIDS defining illness | 1,655 (19.5) | 1,114 (18.6) | 168 (21.1) | 125 (19.1) | 248 (23.2) | 0.001 |
| Requiring prophylactic antibiotics | 3,213 (37.8) | 2,029 (33.9) | 332 (41.6) | 286 (43.7) | 566 (53.0) | <0.0001 |
| Comorbidity | ||||||
| Diabetes | 1,861 (21.9) | 1,356 (22.7) | 153 (19.2) | 120 (18.3) | 232 (21.7) | 0.07 |
| Hypertension | 1,274 (15.0) | 891 (14.9) | 101 (12.7) | 87 (13.3) | 195 (18.3) | 0.07 |
| Malignancy | 849 (10.0) | 554 (9.3) | 74 (9.3) | 65 (9.9) | 159 (14.9) | <0.0001 |
| Psychiatric disorder | 3,431 (40.4) | 2,498 (41.8) | 302 (37.8) | 242 (37.0) | 389 (36.4) | <0.0001 |
| Viral hepatitis | 2,196 (25.8) | 1,608 (26.9) | 201 (25.2) | 165 (25.2) | 222 (20.8) | <0.0001 |
| Financial status | ||||||
| NHI | 7,878 (92.7) | 5,648 (94.4) | 737 (92.4) | 582 (89.0) | 911 (85.3) | <0.0001 |
| National Medical Aid | 623 (7.3) | 333 (5.6) | 61 (7.6) | 72 (11.0) | 157 (14.7) | |
| Hospital type | ||||||
| Designated tertiary hospital | 5,722 (67.3) | 4,044 (67.6) | 540 (67.7) | 449 (68.7) | 689 (64.5) | 0.1 |
| Othersb | 2,779 (32.7) | 1,937 (32.4) | 258 (32.3) | 205 (31.3) | 379 (35.5) | |
| Hospital region | ||||||
| Metropolitan cities | 6,442 (75.8) | 4,516 (75.5) | 613 (76.8) | 515 (78.7) | 798 (74.7) | 0.8 |
| Rural | 2,059 (24.2) | 1,465 (24.5) | 185 (23.2) | 139 (21.3) | 270 (25.3) | |
| Diagnosed year | ||||||
| 2009 | 781 (9.2) | 412 (6.9) | 122 (15.3) | 91 (13.9) | 156 (14.6) | <0.0001 |
| 2010 | 866 (10.2) | 483 (8.1) | 120 (15.0) | 102 (15.6) | 161 (15.1) | |
| 2011 | 965 (11.4) | 568 (9.5) | 136 (17.0) | 98 (15.0) | 163 (15.3) | |
| 2012 | 981 (11.5) | 620 (10.4) | 122 (15.3) | 91 (13.9) | 148 (13.9) | |
| 2013 | 1,098 (12.9) | 777 (13.0) | 96 (12.0) | 88 (13.5) | 137 (12.8) | |
| 2014 | 1,251 (14.7) | 936 (15.6) | 99 (12.4) | 79 (12.1) | 137 (12.8) | |
| 2015 | 1,237 (14.6) | 1,018 (17.0) | 63 (7.9) | 56 (8.6) | 100 (9.4) | |
| 2016 | 1,322 (15.6) | 1,167 (19.5) | 40 (5.0) | 49 (7.5) | 66 (6.2) | |
| Long term follow-up lossc | 477 (5.6) | 16 (0.3) | 30 (3.8) | 208 (31.8) | 223 (20.9) | <0.0001 |
Abbreviation: AIDS, acquired immune deficiency syndrome; HIV, human immunodeficiency virus; NHI, National Health Insurance.
aMantel-Haenszel Chi-Square test to assess trends in the four MPR groups. bOthers of hospital type include public health centres, primary medical clinics, general hospitals. cIndividuals who had no clinic visit for antiretroviral treatment for same or more than a year.